• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CDY:AU

0.0270 AUD 0.0020 8.00%

As of 23:25:06 ET on 10/23/2014.

Snapshot for Cellmid Ltd (CDY)

Open: 0.0250 Day's Range: 0.0250 - 0.0270 Volume: 252,815
Previous Close: 0.0250 52wk Range: 0.0230 - 0.0460 1-Yr Rtn: -27.03%

Stock Chart for CDY

No chart data available.
  • CDY:AU 0.0270
  • 1D
  • 1M
  • 1Y
0.0250
Interactive CDY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CDY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0022
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 19.88
Shares Outstanding (M) 736.19
30 Day Average Volume 1,546,245
Price/Book (mrq) 3.5067
Price/Sale (ttm) 14.8342
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CDY

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for CDY

Cellmid Ltd. researches and develops therapeutic, prognostic and diagnostic products using midkine. Midkine is a heparin binding growth factor used by the company in products involving inflammatory and autoimmune conditions and cancer.

Maria HalaszCEO/Managing DirectorNicholas FalzonJoint Secretary/Controller
Jillian McGregorJoint Secretary
More Company Profile & Key Executives for CDY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil